Pinpoint Surgery

By mich, May 22, 2015

How about something on Stansberry’s latest – “Pinpoint Surgery” stock?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

133
Share your thoughts...

avatar
57 Comment threads
76 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
68 Comment authors
Al RazziSoGiAmWolfgangDONNIE Simseiainc Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

SoGiAm
Member
👍11369

Charles, how ’bout a link to the tout. Does ARAY fit the bill? Accuray Incorporated is a radiation oncology company. The Company develops, manufactures, sells and supports precise, innovative treatment solutions. The Company’s technologies are designed to deliver advanced radiation therapy, including radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy and adaptive radiation therapy tailored to the specific needs of each patient. The Company’s suite of products includes the CyberKnife Systems and the TomoTherapy Systems. The CyberKnife Systems are fully robotic stereotactic radiosurgery systems (SRS) and stereotactic body radiation therapy systems (SBRT), used to treat… Read more »

Add a Topic
15
Add a Topic
3397
SoGiAm
Member
👍11369

Charles, perhaps NVDQ is the equity Stansberry is referring to:
http://novadaq.com/procedures/minimally-invasive-surgery/overview
Enjoy your your Memorial Day! Best-Ben

goldyy
Member
👍5
goldyy

How about OTCPink penny stock: Elekta AB (EKTAF) being Mampilly at Stansberry’s ‘pinpoint surgery’ ‘guaranteed winner? EKTAF is heading up. It Closed $6.77 on 16 JUN 15. It is based in Sweden. Has 3696 employees. It has equipment in thousands of hospitals. It makes the ‘Gamma Knife’. At least I would watch for any announcements.
Company website: http://www.elekta.com/
The Lexsell Gamma Knife® PERFEXIONTM system, manufactured by Sweden-based Elekta
http://www.otcmarkets.com/stock/EKTAF/quote
https://www.google.com/search?q=EKTAF&ie=utf-8&oe=utf-8
http://www.morningstar.com/stocks/PINX/EKTAF/quote.html

Add a Topic
5971
Add a Topic
6225
Add a Topic
2487
toyocoro
Guest
toyocoro

The image from the teaser is right from this Accuray pamphlet poste b “Guest further down on June 19, 2015: http://www.accuray.com/sites/default/files/m-cln-023-1108_lsbrt-cs.pdf

Add a Topic
15
goldyy
Member
👍5
goldyy

Toyocoro: Good find. You are correct! At that ‘Accuray .pdf’ link you gave is the exact same ‘fading lung tumor’ ex-ray’s that Mampilly (Stansberry’s ‘pinpoint surgery’) shows in his ad attempting to get people to fork over thousands for his newsletter.

Add a Topic
15
Add a Topic
6225
Gary Anderson
Member
👍28
Gary Anderson

sogiam, it came to me as an email. Here’s a clip: I’ve discovered a stock that could be biotech’s next blockbuster. It reminds me of a small company I found back in 2000… If you’d put $1,000 into that company (Intuitive Surgical) when I first recommended it on Wall Street, by now you’d have nearly $50,000… a 5,688% gain. And that brings me to the situation we’re facing today…In short, the tiny company I’m now recommending has invented a device that’s revolutionizing cancer surgery on a scale I haven’t seen since 2000… and could very well be the greatest medical… Read more »

Add a Topic
5971
Add a Topic
915
Add a Topic
899
SoGiAm
Member
👍11369

Gary, a bit vague wouldn’t you say? Maybe to avoid the mighty, mighty Think-o-later 🙂
Best-Ben

Gary Anderson
Member
👍28
Gary Anderson

I pulled ARAY 10 Q just for grins. It has some warts that might need precision surgery (grin) before it’s a buy. More later if I find something of interest. Maybe they’ll augment the tease.

Add a Topic
6225
Robert
Guest
Robert

how about NVDQ

SoGiAm
Member
👍11369

Gary, have you ever thought about becoming an Irregular? I’d sure be nice to have another set of eyeballs on the fundamentals and the camaraderie is second to none. Best-Ben

Gary Anderson
Guest
Gary Anderson

Actually, I have considered it. Thanks for the encouragement! I hang out a lot at Value Forum.
Cheers,
Gary

Rick Schroeder
Guest
Rick Schroeder

What’s the name of the company?

modernrock
Irregular
👍236

ARAY

Robert in Stuart
Guest
Robert in Stuart

ARAY is at $5.90 or so, after a fall from $10/share about 6 months ago. The 5-year track is down from about $20/share. Analysts opinions (9) are “very Bearish”. Something is going on, as about 50% of stock is held by major institutions and major funds. Anyone know what?

Add a Topic
5971
modernrock
Irregular
👍236

which free eletter did this come from? has yet to hit my in box

vsyamin
Member
👍20
vsyamin

Here’s more from the pitch: “In short, pinpoint surgery works with a device that targets diseased tissue anywhere in the body… including the brain… head and neck… kidney… lung… pancreas… prostate… and spine — with pinpoint accuracy… …from OUTSIDE the human body… …and REMOVES it in a way you’ve probably never imagined possible. It’s something out of a science fiction movie… And right now — the stock I’m recommending is the ONLY company on the market with FDA approval for the approach it follows… But after waiting 5 years, I’ve determined that right now is the perfect time to make… Read more »

Add a Topic
899
Add a Topic
6225
Add a Topic
4454
alanh
Member
👍4086

I vote cyberknife.

alanh
Member
👍4086
vsyamin
Member
👍20
vsyamin

Yup. It’s Accuray.

Add a Topic
15
richard
Guest
richard

I think it is Novadaq. It is mention in the presentation of Standsberry’s pinpoint surgery that the stock they are talking about is selling for around $10. Accuray is at $6 and Novadaq is at $10. Novadaq was just approved by the FDA as was mentioned in Standsberry. It sounds like Novadaq is more what the investment is talking about.

Add a Topic
6225
Add a Topic
5971
Add a Topic
15
Charles
Guest
Charles

Well, I thought when I was researching it was ARAY as well, however, the stock price did not match up. I did notice in viewing the NVDQ website they use the terminolgy PINPOINT often which ties into the tease terminology? I can’t find anything though about NVDQ signing with one of the biggest hosipal alliances whereas ARAY shows a couple large signings recently?

Add a Topic
5971
JUDY
Guest
JUDY

To al l checked Yhaoo in finance and up comes the company profile for nvdq- a small company from Ontario Canada. It’s near $10 range, read the summary below –it even mentions “PINPOINT” FOR SURGERY. Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products and therapeutic devices for use by surgeons in the operating room and other clinical settings in the United States and internationally. The company’s proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. It offers SPY Elite imaging system for use in coronary artery bypass graft surgery, cardiovascular… Read more »

Add a Topic
1515
Add a Topic
6225
Add a Topic
6225
dthart
Guest
dthart

Seems to be NOVADAQ. Signed agreement w/ Intuitive surgical in 2011(?) and others later, as well. Checked out https://clinicaltrials.gov/ct2/results?term=novadaq&Search=Search
Determines tissue viability via perfusion of ICG to assist in determining patient recovery times. CMS approved payment as an outpatient medical procedure. Don’t see much excitement as a 5,000% monster stock, but probably a double if bought by Intuitive surgical or similar.

Add a Topic
915
Add a Topic
5971
Add a Topic
915
geoko
Member
👍13
geoko

Judy, you ought to be an Irregular, too. You’ll find the $49 well-spent.

alan
Guest

I don’t think it is NVDQ. this company only assists with surgery. The topic in Stansberry discusses the surgical process. a big difference

Add a Topic
6225
B T
Guest
B T

Novadaq appears to be a type systems that allows you see or find the affected area…like and exray… where Accuray is a treatment for cancer…I would go with this. Can anyone find out if the just signed big contracts with major hospitals????

Add a Topic
15
Karl
Guest
Karl

so is it ARAY or NVDQ? Is ARAY a worthwhile investment?

Gary Stoltz
Guest
Gary Stoltz

Both are held in high numbers by the money makers but I can’t pinpoint it.

DBMD
Irregular
👍1097
DBMD

I’ve been in NVDQ, but sold out a month or so ago. It may be a CAR-T play as it is pinpoint and outside the body. Dr. Eifrig has touted this before. Alternately, Accurexa is a Ab nano particle that under magnetic induction kills the CA and sounds like SF, but not the right price range.

Add a Topic
5805
Add a Topic
5916
Uncle Albert
Guest
Uncle Albert

So we have two candidates for the tease and no agreement yet on which or what company is being teased

SoGiAm
Member
👍11369

“Uncle Albert/Admiral Halsey” By Paul McCartney
https://www.youtube.com/watch?v=XsWufNDJl4M It fit’s ARAY website: http://www.accuray.com/ pretty well with no further information. Best-Ben

MikeD
Guest
MikeD

I agree with sogiam’s assessment above. The email from Stansberry says the price is under $10 which ARAY is and NVDQ is not. Also, NVDQ offer imaging solutions, with “pinpoint” imaging accuracy. But these are for use in traditional surgery, not something new and alternative.

Add a Topic
5916
Add a Topic
6225
Js
Guest
Js

The only thing is he says it isn’t a traditional play. So does he mean options or something totally different.

Add a Topic
570
Jimmy C
Guest
Jimmy C

You’re talking $6, $10 stock… Stansberry guy obviously composed his presentation over a period of time. Mid April, ARAY was a $10 stock before it got hit by bad earnings.

Add a Topic
5971
Add a Topic
5971
alanh
Member
👍4086

Gosh!!! Youre paying $2500 to get info about a stock that was $10 and is now $6….bargain!!!!

Add a Topic
5971
B T
Guest
B T

I believe ARAY it appears to be more of a treatment for cancer as mentioned in the tease and NVDQ appears to be more of a tool or device like an ex-ray that would help you see the affected area better. The also mention just signing with a big hospital anyone got any info this this????

Add a Topic
3397
joseph
Guest

Travis, Could you provide further insight into the company touted by Paul Mampilly?

Add a Topic
2799
SoGiAm
Member
👍11369

BIOZF, Biotie- I know Alan is gonna throw tomatoes at me 😉 https://globenewswire.com/news-release/2015/05/25/738679/0/en/Biotie-announces-agreement-with-FDA-on-a-Special-Protocol-Assessment-for-tozadenant-Phase-3-study.html Best2ALL-Benjamin!

modernrock
Irregular
👍236

It is ARRY recently almost $10 just within the last two months.

modernrock
Irregular
👍236

ARAY not ARRY, sorry

Uncle Albert
Guest
Uncle Albert

Using our collective Think-O-Lator hats, I think we have come up with ARAY as the teased “pinpoint surgery” stock…thanking you all for your inputs and mystery-solving skills

Add a Topic
6225
1paglee
Member
👍237
1paglee

I agree with giving a preference to ARAY. However, there’s a Swedish company named Elektra AB that produces a somewhat similar external treatment system called GammaKnife utilizing nuclear radiation, and is regulated by the NRC. There are two U.S. symbols EKTAY and EKTAF, both priced slightly over $7. I found that Cooper University has a new treatment center around 3 miles from my home in Moorestown, NJ that features both kinds of external radiation treatment. Here’s a link: http://www.cooperhealth.org/treatments/radiosurgery Any more comments? We would particularly welcome one from you, Travis, if you happen to read this.

Chuck
Guest
Chuck

I could not find any indication that ARAY received the big contract mentioned in the tease. Does anyone have any information on this issue as to ARAY or Elektra or anyone else?

modernrock
Irregular
👍236

It is ARAY and has been confirmed.

chazman7
Member
👍4
chazman7

Chuck, if you go to the ARAY website under press releases I found several key strategic alliances but the most recent is with Premeir with over 3,000 hospitals and an additional 100,000 contacts. I also checked other reference such as the Stanford Study and others and find references to these as well so I am pretty sure the company is ARAY at this point. The analysis for this has recently joined Stansbury newletter but prior to that I believe he was with Agora Publishing?

Add a Topic
5916
Add a Topic
6137
Chuck
Guest
Chuck

Thanks. It sounds like you have found what I was looking for. I was drawn to ARAY years ago and followed it now and then. It has always suffered from less than stellar management. They still can’t seem to make a profit. Maybe this contract will pay off and give it the lift-off it needs. Today it dropped below $6 a share, so the price is getting more interesting. Of course the drop from near $10 was due to “earnings” (really a bigger loss than anticipated) disappointment.

Add a Topic
372
B T
Guest
B T

I agree ARAY is the logical choice, and with this information about the hospital contracts, it makes selecting ARAY more solid….. so what else are we waiting for????

Lee Woolman
Guest
Lee Woolman

Accuray Inc (ARAY) signed 3-year contracts with Amerinet and Novation in May of 2014.

Add a Topic
15
Js
Guest
Js

http://www.itnonline.com/article/accuray…solutions-contract-premier-inc
September 9, 2014 — Accuray Inc. announced it has been awarded a new exclusive three-year group purchasing agreement with Premier Inc., covering the CyberKnife …

Could this be the agreement?

Add a Topic
15
Add a Topic
15
Shanghai
Guest
Shanghai

It’s interesting that Cyberknife got an FDA approval in 2001 and Accuray’s business hasn’t been succeded for 14 years. Agreement with Premier sounds good, but I am a bit sceptic.
What’s your opinion about it?

Add a Topic
3022
kbantis
Member
👍0
kbantis

I was in ARAY years ago, probably from a teaser ad. It was at the time that they were just turning profitable I researched and decided that they were going to announce earnings and go from losing $.07/shr to making $.07/shr. I bought shares and calls and they did make $.07 at the next earnings but when they announced earnings management had awarded $.06/shr. to themselves as bonuses and only$.01/shr. was left for shareholders who then proceeded to sell the stock down to approximately 50% of the pre-earnings value. I have not owned ARAY since.

Add a Topic
5971
Doc
Guest

http://www.tucc.com/SBRT-Cyberknife-for-prostate-cancer-may-result-in-more-complications.29.564.html
It is definitely ARAY.
In this trial 55 patients with medically inoperable peripheral tumors (non-small cell lung cancer stages 1A and 1B) were given three treatments of SBRT. They had tumor control in 98% of the patients, 72% survival at two years and a median overall survival of 48 months.

Add a Topic
4555
Add a Topic
3397
eyedoc
Member
👍3556
eyedoc

How disappointing. At the present time, the tease falls flat on its face. The hospitals around Newport Beach, CA have had all of ARAYs products and been a showplace for them for years. It is a very impressive bunch of VERY expensive machines that do things that were unimaginable 15 years ago. There is very little collateral damage to surrounding tissues from SBRT. They have some problems, though.: 1) There is no way to tell if the tumor margins are clear. The tumors treated by SBRT can recur both locally and distantly. 2) It is radiation. It is taken up… Read more »

Add a Topic
3397
Chuck
Guest
Chuck

Thanks, eyedoc. I agree with you. Maybe InSightec will be spun off as a separate entity some day. That might be worth considering. ARAY is not that attractive to me (and the price is still dropping today, on an up day, after all the Stansberry touting).

geoko
Member
👍13
geoko

That TED talk was wonderful. This concept gives options that didn’t exist before.

Add a Topic
570